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MIPAbstract Objective: This study aimed to check the sensitivity of multiple newly developed 3T
MRI breast sequences using CAD software, in pre-sampling diagnosis of breast cancer, in an
attempt to minimize unnecessary invasive sampling or surgical procedures.
Patients and methods: This was a prospective study, included 120 female patients, presented with
debatable or malignancy suspected mammo-sonographic results. The study protocol was approved
by the ethics committee in Al-Mana General Hospital.
Results: 36 patients’ tumors were reported as benign and 84 were reported as malignant. Biopsy
approved 33 tumors as benign and 87 as malignant tumors. These results gave indices of 93.1% sen-
sitivity and 90.9% speciﬁcity.
Conclusion: 3T MRI breast with CAD is very sensitive imaging tool, that can help to avoid unnec-
essary invasive procedures.
ª 2014 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Breast cancer has a tremendous impact on women’s morbidity
and mortality, worldwide. It is the most common cancer in
females, as it accounts for about 22% of all malignant tumors
in women. In Saudi Arabia, the incidence of breast cancer is
about 19.9%. Average age of presentation is considerably var-
iable from area to area; in the United States, 50% of breast
cancer occurs in women over the age of 65 years, while in Mid-
dle East countries, including Saudi Arabia, it is signiﬁcantly
presented at earlier age groups; average below 52 years.1,2
10 M. Agha et al.It is the second leading cause of cancer deaths in KSA. This
malignancy carries tremendous worldwide health care, socio-
economic, emotional and public health implications. There
are many risk factors classifying some women as high risk
groups for developing such disease, some of these factors are
avoidable and others are not.1
1.1. Unavoidable risk factors
1.1.1. Gender and age
Breast cancer occurs nearly 100 times more often in women
than in men. Risk of developing breast cancer increases for
women that are getting older. About 1 out of 8 invasive breast
cancers are found in women younger than 45, while about 2 of
breast cancers out of 8 are found in women age 55 or older.3,4
1.1.2. Genetic risk factors and family history
5–10% of breast cancer cases are thought to be hereditary, due
to an inherited chromosomal anomaly in the BRCA1 and
BRCA2 genes. Breast cancer risk is higher among women with
close relatives’ history of breast cancer. Having one ﬁrst-degree
relative with breast cancer approximately doubles a woman’s
risk. Having 2 ﬁrst-degree relatives increases her risk about
3-fold.5,6
1.1.3. Personal history and racial ethnicity
A woman with cancer in one breast has 3- to 4-folds increased
risk of developing a new cancer in the other breast or in
another part of the same breast. Overall, western women are
slightly more likely to develop breast cancer than African
women, but African women are more likely to die of this can-
cer. Asian, Hispanic, and Native-American women have a
lower risk of developing and dying from breast cancer.7–9
1.1.4. Dense breast tissue and certain benign breast conditions
Breasts are made up of dense glandular and ﬁbrous tissue and
less fatty tissue, have a higher risk of breast cancer than
women with less dense breasts. Unfortunately, malignant
lesions can be easily missed in dense breast mammograms. A
number of factors can affect breast density, such as age, men-
opausal status, the use of drugs (e.g. Post menopausal hor-
monal therapy), pregnancy, and genetics. Women with
multiple ﬁbroadenomas have an increased risk of breast cancer
– about 1½ to 2 times. Also, sclerosing adenosis, papillomatosi
and radial scars slightly increase the risk of developing breast
cancer.10–12
1.2. Avoidable risk factors
1.2.1. Nonpregnant and nonlactating females
Women who had no children or who had their ﬁrst child
after age 30 have a slightly higher breast cancer risk. Preg-
nancy reduces a woman’s total number of lifetime menstrual
cycles, which may be the reason for this effect. Also, some
studies suggest that breast feeding may slightly lower breast
cancer risk, especially if it is continued for 1½ to 2 years.
One explanation for this possible effect may be that
breastfeeding reduces a woman’s total number of lifetime
menstrual cycles.131.2.2. Birth control and postmenopausal hormonal replacement
therapy (PHT)
Oral contraceptives have been proven to slightly increase the
risk of breast cancer, than women who have never used them,
especially if taken by BRCA1&2 carriers. Also PHT, although
relieving many of postmenopausal complaints e.g. osteoporo-
sis, it signiﬁcantly increases the risk of getting breast cancer,
as well as the chances of bad prognosis.14
1.2.3. Alcohol
Compared with non-drinkers, women who have 2–5 drinks
daily have about 1½ times the risk of women who do not
drink alcohol. Excessive alcohol consumption is also known
to increase the risk of developing several other types of
cancer.151.2.4. Breast imaging
Still mammography is the ﬁrst and most commonly used imag-
ing tool for initial breast evaluation. In 2000, the Dutch Insti-
tute for Health Care Improvement had established a
mammographic imaging protocol called, Breast Imaging
Reporting and Data System (BI-RADS) for breast imaging.
This system was formatted to have standard items including,
indication for the study, class of breast composition, all posi-
tive ﬁndings, type of calciﬁcation and associated changes e.g.
skin thickening, and axillary lymph nodes, if present and
changes from older studies. Thereafter, breast will be classiﬁed
under one of 6 standard BI-RAD classes; ranging from normal
breast (Type 1) to proven malignancy (type 6). Finally, suitable
management is suggested according to the reported class, e.g.
biopsy for grade 4.16
Annual screening mammography for females is recom-
mended, starting at age 40, for early discovery of malignant
lesions. However, there is one great disadvantage of breast
cancer mammographic screening, which is the false-positive
result. This disadvantage may lead to unnecessary work out
and sometimes invasive procedures, thus, not cost effective
and provoking anxiety in women before malignancy could be
ruled out. Regardless, there is signiﬁcant improvement of the
results, after advent of the digital mammography into practice,
there is still false positive results in considerable percentage
of patients. In an article published by Hobson K, in Wall
Street Journal at October 2011, a wide USA statistic study
detected that 60% of women following the schedule of annual
mammograms were falsely recalled for additional imaging e.g.
other mammographic views, or Ultrasound, or MRI, or biopsy
procedures.17
Regardless, MRI is very sensitive soft tissues imaging tool,
its application in breast imaging is not frequent, especially in
Middle East. Some institutes use MRI breast, only as preoper-
ative imaging tool, in pathologically proven cases of cancer
breast, in attempt for clear demonstration of lesions, and if
there are another mammographically missed lesions that may
change the plan of management. Also, it may be recommended
in postoperative evaluation for residual or recurrent lesions or
response to neoadjuvant therapy.18 Due to its relative high
cost, there is no many researches for the evaluation of the
use of MRI as periodic screening tool, instead of
mammography.
3T MRI of the breast with computer aided diagnosis 111.2.5. Objective
This study aimed to test the highest possible accuracy of breast
MRI using combined standardized quantitative and qualitative
analysis of imaging data and its diagnostic potential. This may
have potential impact of reduction of unnecessary intervention
procedures and patients’ stress for benign lesions with contro-
versial mammographic ﬁndings, especially in high risk patients.
2. Patients and methods
2.1. Population of the study
In Almana General Hospital (AGH)-Eastern Province, Saudi
Arabia- from June 2012 until March 2014, 120 patients were
found to have either controversial or malignant looking breast
lesions, through both mammographic and sonographic exam-
inations i.e. consistent with BI-RAD 4 or 5 classes, respec-
tively. After installation of 3T MRI, we had applied a new
protocol for these suspected breast lesions, which includes
MRI examination before biopsy procedure.
All patients had signed informed consent in compliance
with the hospital review board. MRI was performed shortly
after mammographic-ultrasound examination, dated at the
ﬁrst two weeks of menstrual cycle for premenopausal ladies.
2.2. Methods
All MRI examinations were done throughMagnetom Verio 3T
machine, Siemens AG. Wittelsbacherplatz 280333, Muenchen,
Germany. Imaging was performed using a bilateral breast array
dedicated surface coil. Contrast was given through power injec-
tor (MRI compatible Bracco Empower Injector- Siemens AG
Henkestrasse 127 D-91052 Erlangen-Germany). The patients
were imaged in prone position, with both breasts centralized
in the breast coil. In an attempt to avoid aliasing artifacts,
which may occur in large breasts, smooth compression with
sponge pads was done. On the contrary, if breasts were too
small, foam wedge supports were inserted inside the coil, in
order to limit respiratory movement artifacts.19
Our imaging protocols were consisted of axial STIR, coro-
nal T2w and sagittal T1w sequences. Afterward, DWI of both
breasts was performed in the axial plane using single-shot
echo-planar sequence, with 3 different b values; 0, 800 and
1500 s/mm2, respectively 2. Finally, dynamic contrast
enhancement sequence (DCE) was applied, as one pre- and 4
postcontrast axial T1w fat sat sequences. A single contrast
dose (0.2 mL/kg) was injected at a rate of 2 mL/s, followed
by 20 mL normal saline ﬂush, at a rate of 1 mL/s.
Average imaging parameters in DCE sequences were: 5 mm
slice thickness interpolated to 2.5 mm intervals; matrix:
317 · 512; ﬁeld of view: 16–18 cm2, ﬂip angle, 25. The total
duration of the dynamic study was approximately 8–10 min.
The patient afterward were removed fromMRI, and scheduled
for mammographic stereotactic or free hand ultrasound guided
biopsy within one week.
2.3. Post-processing
This study applied standard evaluation system for all
examined patients, including qualitative and quantitativeparameters. These Qualitative items were: shape and borders
of the lesion, Tw2 signal intensity, being single or multifocal
or multicentric or bilateral, edema if present; including its
degree of extension, septations if present and their enhance-
ment pattern, inner architecture distortion if present, diffusion
restriction, nipple retraction, skin and areolar thickening, vas-
cularity of the lesion and axillary lymphadenopathy.
Quantitative post-processing was done through computer
aided diagnostic (CAD) software, aiming to achieve the possi-
ble highest MRI examinations diagnostic sensitivity. This
included evaluation of DCE sequences through recording
post-contrast peak enhancement percentage value, time, pat-
tern of enhancement (homogenous or heterogeneous or ring)
and DCE curve type. Three types of DCE curves could be
obtained, giving three different scores for evaluation. In
type-I (continuous) curve; there is continuously increasing
enhancement with no decline allover sequence time. In type-
II (plateau) curve, the post-contrast enhancement shows peak
enhancement, then it becomes ﬁxed over time with no or less
than 10% changes. In the Type-III (washout) curve; enhance-
ment signiﬁcantly decreases after initial rise.
Also one of the useful CAD software used in this study is the
post-processing subtraction applied to pre-and post-contrast
dynamic sequences in all phases i.e. subtracting pre-contrast
from post-contrast images. This gave 4 subtracted sequences,
eliminating all non-enhanced tissues e.g. Residual nonsup-
pressed fatty tissues and glandular tissue that may distort the
clear visualization and evaluation of the enhancing lesions. Vas-
cular scoring was made through maximum intensity projection
(MIP) ﬁlter, which enables measurements of length and diame-
ter of neoplastic feeding vessels. This gave four grades of vascu-
larity of the examined breast tumors, ranging from 0 to 3.
Diffusion-weighted MRI (DWI) had been applied, includ-
ing both qualitative and quantitative measures. This sequence
is sensitive for diagnosis and estimation of the degree of diffu-
sion restriction by tumor cells. It can help in diagnosis by dif-
ferentiating condensed cellularity of malignant tumors from
less condensed benign lesions. For quantitative analysis of
the data acquired from DWI, ADC maps were automatically
created, using software provided by the MRI system manufac-
turer (Syngo, Siemens Healthcare) using three b values (50,
800, and 1500 s/mm2). Tumors having ADC values less than
(1.05 · 103 mm2/s) were widely considered malignant.20
In an attempt for limitation of subjective MRI readers’
false results, we adapted scoring system for all MRI examina-
tion signs from Malich et al. who adapted Fischer’s scoring21
with some little modiﬁcation adding DW sequence results
instead of blooming sign. These evaluation criteria were stan-
dardized for all patients with given points ranging from 3 to
3 for each character according to its benign or malignant fea-
tures, respectively. If the total scores P5, the examined lesion
was considered malignant, in contrast to lesions with scores
<5, that were considered benign lesions (Table 1).
2.4. Results
Through a standard scoring system; post-imaging evaluation
through items of scoring gave the following results: (Table 1).
T2 signal was given score ranging from 3 to 1, inversely
proportionate to its signal intensity. Average of this point
was 2.2 for proven benign lesions and 0.2 for proven
Table 1 Scoring points and sum for biopsy proven (BP) benign and malignant lesions.21
Character Score Average for BP. benign Average for BP. malignant
T2
Hyperintense 3 2.2 0.2
Hypointense 1
Edema
No edema 1 0.8 1.3
Bilateral, bifocal, diﬀuse 1
Unifocal, unilateral 2
Hook sign
Positive 1 0 0.3
Negative 0
Skin thickening
Positive 1 0.1 0.6
Negative 0
DWI
Restricted diﬀusion 2 0.6 1.6
No restriction 0
Vascular score
Absent 0
Low 1 1.8 1.3
Moderate 2
High 3
Margins of contrast enhanced lesion
Well-deﬁned 0 0.3 0.6
Ill-deﬁned 1
Shape of contrast-enhanced lesion
Round, lobular, oval 0 0 0.7
Linear, dendritic, stellate 1
Enhancement pattern
Homogeneous 0 0.1 0.8
Inhomogeneous 1
Initial peak signal intensity increase
<50% 0 1.8
50–100% 1
>100% 2 0.5
DCE curve
Continuous raise 0 0.3 1.7
Plateau 1
Wash-out 2
Lymph nodes 0
No lymph nodes 0 0.6 0.7
<10 mm 1
>10 mm
Sum of average scoring points 1.3 11.6
12 M. Agha et al.malignant lesions (Figs. 1–3). Edema was scored 1 if not
found, 2 if bilateral or multifocal or diffuse and 2 if localized
unilateral. Average for benign lesions was 0.8, while for
malignant lesions was 1.3 (Fig. 1A). Hook or dendrite sign;
if positive, it was given 1, if not it was given 0. It is not seen
in any benign lesions, while average score was 0.3 for malig-
nant swellings (Figs. 1B and 2A).
Skin thickening was scored 1 if present and 0 if absent;
averaging 0.1 in benign lesions and 0.6 for malignant ones
(Figs. 2 and 4B). If the tumor showed restricted diffusion
at DWI, it was scored 2, if not it was scored 0 giving aver-
age of 0.6 for benign lesions and 1.6 for malignancy(Fig. 3B and D). Vascularity of lesions was classiﬁed into
4 grades ranging for absent (0) to high (4); average score
was 1.3 for benign lesions and 2.4 for malignant lesions
(Figs. 4 and 5).
Postcontrast scoring had included wall deﬁnition of the
swelling; 0 if well-deﬁned and 1 if not well deﬁned. Average
was 0.3 for benign and 0.6 for malignant swellings. Also, post-
contrast shape of the swelling; 0 if smoothly rounded or mac-
rolobular and 1 if irregular or speculated; averaging 0 for
benign and 0.7 for malignant lesions. Enhancement pattern,
if homogenous was given 0 if heterogeneous it was given 1,
averaging 0.1 for benign and 0.7 for malignant lesions.
A B
Figure 1 (A) Axial T2w image showing left breast hypointense (proven malignant) nodule (arrow) and right breast incidentally
discovered small well deﬁned benign looking hyperintense nodules (arrowheads). (B) Another patient with right breast malignant T2w
hypointense inﬁltrative tumor with dendritic outline (arrow).
A B
Figure 2 (A and B). Left breast proven malignant tumor: axial STIR images show left breast long TR hypointense swelling (arrowhead)
with localized perifocal edema, asymmetrical skin thickening (arrow in B), dendritic inﬁltrative outline and positive hook sign (curved
arrow).
3T MRI of the breast with computer aided diagnosis 13Enhancement intensity peak was expressed as percent in
correlation with initial precontrast intensity; giving 0
if < 50%, 1 if 50–100% and 2 if > 100%. Average score
was 0.5 for benign lesions and 1.8 for malignant lesions.
DCE curve shape was scored 0, if it was continually raising
curve, 1 if plateau and 2 if showing washout. This gave average
score 0.3 for benign tumors and 1.7 for malignant tumors
(Figs. 4–6). Axillary lymphadenopathy if not seen or smaller
than 10 mm, it got 0 score; if more than 10 mm it was scored
1. This resulted in average 0.6 for benign lesions and 0.7 for
malignant lesions. All these parameters collectively gave sum
of 1.3 for benign lesions and 11.6 for malignant lesions.
Before biopsy, MRI results had been interpreted for 36
patients’ swellings as benign tumors (MRI scoring points
sum < 5 points). The other 84 patients’ tumors were reported
malignant; having scoreP 5 points. 30 of these 36 MRI had
been approved to be benign tumors, to be benign, while 6
had pathological diagnosis of being malignant. Of those 84
imaging reported malignant tumors, 81 tumors had patholog-
ical conﬁrmation of being malignant. This means that there
were 81 true positive and only 3 false positive cases, as wellas 30 true negative and 6 false negative cases. These results
gave indices of 93.1% sensitivity, 91.9% speciﬁcity, 96.4%
positive predictive value (PPV) and 83.3% negative predictive
value (NPV) Table 2.3. Discussion
MRI is expected to be sensitive tool of imaging for diagnosis,
staging, and post-therapeutic follow up of breast cancer. Some
newly applied imaging sequences had noticeably increased
accuracy and sensitivity of MRI breast imaging. In an attempt
to obtain the best results, we used combination of data
obtained from morphology of the lesions and associated sur-
rounding tissues changes in different sequences, as well as post-
contrast dynamic changes i.e. utilizing the high spatial and
high temporal resolution criteria of MRI examinations.
First of the evaluating items was T2w signal intensity of the
lesion; T2w hypointensity favors the diagnosis of malignancy,
while T2w hyperintensity supports benign diagnosis. This
could be explained by the fact that, T2w hyperintensity reﬂects
A B
C   D
Figure 3 (A) T2w image, of right breast proven malignant tumor, shows irregular hypointense lesion (arrow), (B) ADC the lesion shows
remarkable restricted diffusion, seen as low signal intensity. (C) Another patient with left breast benign swellings showing T2w
Hyperintense signal (arrows). (D) No restricted diffusion at all in DWI.
A B C
D E
Figure 4 (A) US left breast showing central hypoechoic soft tissue lesion with highly suspicious malignant features (arrow). (B) STIR
axial MRI image showing associated skin thickening with the lesion (arrow), and epsilateral axillary lymphadenopathy (notched arrow)
together with diffusion restriction seen in ADC image (arrow in C) raise the malignant suspicion. (D) MIP for post-contrast axial T1w fat
sat image shows grade I vascularity as relatively engorged local vascularity with slightly increased caliber. (E) DCE curve shows
continuously raising curve consistent with benign nature of the swelling, chronic inﬂammatory process (granulomatous mastitis) was the
pathological result of US guided biopsy.
14 M. Agha et al.high water and/ or fat contents that are usual components of
benign lesions. T2w low signal intensity might be secondary
to collagen-rich ﬁbrous tissue with low water and fat contents,
which is known histopathological sign of malignancy.22,23Scores for this item was arranged from 3 to 1 according to
signal intensity percentage (Table 1).
Localized perifocal edema had been more commonly seen
with malignant lesions. This might be attributed to the fact
Figure 5 (A and B) Right breast ML mammogram and US breast show central nodule which was suspected to be malignant due to dense
acoustic shadow in US. (C) MRI T1 postcontrast T1 fat sat showed avid post-contrast enhancement of the lesion. MIP images of early (D)
and delayed (E) phases of dynamic postcontrast sequence show low vascular score (1) with no new angiogenesis. This together with benign
continuously raising DCE curve (F) had supported the benign radiological diagnosis. (Pathologically proven traumatic fat necrosis with
ﬁbrous scar).
3T MRI of the breast with computer aided diagnosis 15that, the malignant neoplastic vessels induced by neoangiogen-
esis have less intact basal membranes, leading to higher pene-
tration of ﬂuid and perifocal edema. Also, neoplastic
proliferating cells produce large amounts of endothelium and
vascular permeability destroying agents; with secondary
increased permeability of neoplastic blood vessels.24 Epsilater-
al asymmetrical skin thickening with breast tumors had got
higher scores in association with malignancy in comparison
with low score of benign lesions. This is due to subcutaneous
lymphatic system clog by tumor cells. Asymmetrical skin
thickening more than 5 mm should be considered suspicious
for malignancy.25,24
Edema may be found in other different types of breast
lesions e.g. inﬂammatory lesions, however, it will be more dif-
fuse and not strictly limited to the focal lesion area.25
DWI is very informative sensitive sequence with valuable
qualitative and quantitative analysis, because malignant tumors
usually had restricted water molecular diffusion. The diffusivity
of water molecules is restricted in malignant tumors, due to
compact high cellularity, intracellular and extracellular edema,
and high viscosity.24,26 In study published by Woodhams et al.
20 for comparison between ADC values of benign and malig-
nant breast tumors, ADC values were signiﬁcantly lower in
malignant tumors being less than 1.6 · 10(3) mm2/s with 95%
sensitivity. In our study, we standardized this ﬁgure for DWI
in differential diagnosis of malignant from benign lesions. Pro-
ven malignant lesions had signiﬁcantly higher scores of diffu-
sion restriction in comparison with benign lesions Table 1.A sure sign of aggressive inﬁltrating extension of malignant
lesions is the speculated deeply extended irregular linear den-
drites (hook sign), it had never been detected in any benign
lesions. So, this hook sign can be conﬁdently reported as sign
of malignancy.24 Vascular scoring is another moderately effec-
tive differentiating point. Malignant lesions had higher average
scores, in comparison with benign lesions. This could be
explained by new angiogenesis of malignant lesions, as angio-
genesis is a key event in the uncontrolled progression of malig-
nancy. Tumor angiogenesis involves multiple cellular processes
including endothelial cell proliferation, migration and reorga-
nization of extracellular matrix.26
One of the most valuable sequences is the dynamic
enhancement sequence (DCE), with many published literatures
supporting its accuracy and sensitivity.27,28 Also, use of CAD
software facilities that apply subtraction for post-contrast
images, allowing kinetic analysis of the soft tissue tumors at,
had signiﬁcantly improved the sensitivity of DCE sequence.
Early post-contrast enhancement peak (before 3 min), with
high signal percentage value (more than 100% increase of ini-
tial tumor signal) and early washout (more than 20% signal
intensity loss) within the time of the dynamic sequences are
highly sensitive signs for diagnosis of malignancy.26
This speciﬁc malignant pattern of enhancement could be
explained by the abnormal development of malignant
neovascularity, which lacks capillary network and contains
multiple microscopic arteriovenous ﬁstulae, causing rapid
washout of contrast without capillary phase. Plateau type
Figure 6 (A) CC mammogram showing left breast pathologically proven malignant nodule. (B) DCE curve of the lesion seen in A
showing early peak with rapid washout (malignant curve). (C) Plateau curve for another malignant lesion of the right breast (D). (E) CC
mammogram showing right breast pathologically proven benign nodule, (F) DCE curve demonstrating continuos rising enhancement
(benign enhancement curve), (G) table of sequential ROI measures in DCE study showing continuos raising ﬁgures.
16 M. Agha et al.of DCE curve has relatively lower scoring points for malig-
nancy, than the washout pattern. As documented in pub-
lished researches, kinetic values of DCE curve, washout
and early enhancement peak favor diagnosis of malignancy
with sensitivity more than 80%. While, plateau curve is
consistent with only 60% malignant possibility, in compar-
ison with the continuous raising curve, which supports
diagnosis of benign swellings, with less than 20% malignant
possibility.21,27–29Axillary lymphadenopathy is relatively weak differentiating
point with score ranging from 1 to 1, according to its absence
or presence and size. This is because they can coexist with
either benign of malignant lesions. Only if it shows the criteria
which favors diagnosis of nodal metastasis, it will be support-
ive sign. These criteria include size if > 2 cm at its short axis,
lost fatty hilum and rounded contour. As regards such
parameter in the study, benign lesions had average score point
of 0.6, in comparison with malignant lesions score which was
Table 2 Results of the MRI examinations.
Score range No. of patients B.P. benign B.P. malignant Sensitivity % Speciﬁcity % PPV % NPV %
<5 36 30 6 93.1 90.9 96.4 83.3
P5 84 3 81
Total 120 33 87
No.: number, B.P: biopsy proven.
Sensitivity: true positive/true positive + false negative.
Speciﬁcity = true negative/true negative + false positive.
PPV (positive predictive value) = true positive/true positive + false positive.
NPV (negative predictive value) = true negative/true negative + false positive.
3T MRI of the breast with computer aided diagnosis 170.7, therefore it was not a considerable differentiating param-
eter in discrimination of the lesions.30
Based on our experience through this study, magnetic reso-
nance imaging (MRI) is highly sensitive imaging modality for
breast cancer diagnosis. It clearly detected primary lesions and
show their extent, as well as additional malignant foci that may
be missed by mammographic imaging. Also, continued
advances in computer software had much improved MRI’s
diagnostic sensitivity, allowing to avoid unnecessary interven-
tional breast procedures.
4. Conclusion
 MRI is very sensitive imaging tool for diagnosis of mammo-
graphic and or sonographic debatable lesions.
 To attain such successful results, there are standardized
technical protocols for breast MRI examination should be
carefully followed.
 This necessitates application of different MRI sequences
with correlation of each sequence positive data to standard
scoring system.
 Post-processing CAD software tools had undoubtedly
increased diagnostic sensitivity of MRI examinations of
breast tumors.5. Recommendation
MRI breast examination is recommended to be applied not
only for evaluation of debatable breast lesions seen, but also
as screening tool at least once every two years for breast cancer
high risk females. This protocol aims for early detection of
cancer breast, which may be missed for long time of repeated
scanning with conventional mammogram.
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